Kenvue stock has gained 10.5% year to date, yet the latest Discounted Cash Flow (DCF) intrinsic value estimate still points to a meaningful gap between the share price and the modelled value. At the same time, broader valuation checks and market multiples suggest a more balanced picture rather than an obvious bargain.
- The 10.5% year to date return suggests sentiment toward Kenvue has improved in 2026, even though the share price remains below its level a year ago.
- Recent earnings that came in slightly soft and ongoing execution on margin and cash flow are likely to be key drivers of how quickly any gap to intrinsic value can close. In addition, the pending combination with Kimberly Clark may add uncertainty around how the future cash flow profile will be shared between current and new shareholders.
- With a 3 out of 6 valuation score, Kenvue shows a mixed picture rather than a clear bargain or clear overvaluation on the wider set of checks.
The issue now is whether the current discount suggested by the DCF intrinsic value estimate, around 37.2%, offers enough compensation for the execution risks and structural changes facing Kenvue.
Is Kenvue Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here values Kenvue by projecting the cash it may generate for shareholders over time. The latest twelve month free cash flow is about $1.84b, and the model assumes those cash flows continue growing from this base rather than relying on an aggressive rebound story. On that set of inputs, the 2 Stage Free Cash Flow to Equity model points to an intrinsic value of about $30.47 per share.
At this level, the DCF output implies Kenvue trades at roughly a 37.2% discount to the modelled value. The recent Q2 2026 earnings miss and the uncertainty around the pending Kimberly Clark combination help explain why the market price may still sit below what the cash flow stream suggests. If execution on margins and cash generation holds close to these assumptions, the current gap between price and estimated value remains significant.
Overall, the DCF workup indicates that, under these assumptions, Kenvue stock appears undervalued relative to its projected cash flows.
Our Discounted Cash Flow (DCF) analysis suggests Kenvue is undervalued by 37.2%. Track this in your watchlist or portfolio, or discover 52 more high quality undervalued stocks.
Is Kenvue Fairly Priced on Earnings?
P/E is a useful cross check for Kenvue because earnings remain a key focus for consumer health investors. Kenvue currently trades on a P/E of about 22.2x, which is above the Personal Products industry average of roughly 18.3x but below the peer group average of about 34.1x. That places the stock in the middle of the pack, not at a clear discount or on an extreme premium relative to similar companies.
The Fair P/E Ratio model, which blends factors such as Kenvue’s sector, profitability profile and risk, points to a figure of about 21.4x. This is only slightly below the current P/E, so the gap is small. Taken together with the softer recent earnings and the pending Kimberly Clark combination, the multiple suggests investors are paying a price that is broadly aligned with Kenvue’s current earnings stream rather than a clear bargain or an obviously stretched valuation.
On the P/E multiple, Kenvue stock appears priced broadly in line with what the Fair Ratio model would suggest.
See what the numbers say about this price — find out in our valuation breakdown.
The Kenvue Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives for Kenvue pick up where the valuation work leaves off and spell out which specific paths for Kenvue’s growth, margins and earnings would need to play out for the stock to be worth materially more or less than today’s price, based on current models. Where a single ratio or DCF output gives one figure, the Narratives describe the future it relies on so you can watch how closely reality tracks that story over time on the Community page.
Be one of the first voices in the Simply Wall St community to set out a clear, number driven narrative on Kenvue that others can track as new results, the dividend increase and the pending Kimberly Clark combination play through. Share a view on whether Kenvue’s earnings, margins and cash flows support today’s price or point to a different outcome over time.
Do you think there’s more to the story for Kenvue? Head over to our Community to see what others are saying!
The Bottom Line
For Kenvue, the Discounted Cash Flow (DCF) work points to an intrinsic value that is meaningfully above the current share price, while the P/E based view looks about right against peers. That mix leaves the stock screening as undervalued on cash flows but only mixed once the wider checks are included. The crux is whether Kenvue can sustain margins and cash generation as the Kimberly Clark combination is finalised. The key question for investors is whether the current discount reflects a mispricing of that execution risk or a fair caution on how future cash flows are shared and delivered.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Kenvue might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Source link
